Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

408 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis.
Bomsztyk J, Ravichandran S, Giles HV, Wright N, Berlanga O, Khwaja J, Mahmood S, Wisniowski B, Cohen O, Foard D, Gilbertson J, Rauf MU, Starr N, Martinez-Naharro A, Venneri L, Whelan C, Fontana M, Hawkins PN, Gillmore JD, Lachmann H, Harding S, Pratt G, Wechalekar AD. Bomsztyk J, et al. Among authors: ravichandran s. Blood. 2024 Mar 28;143(13):1259-1268. doi: 10.1182/blood.2023022399. Blood. 2024. PMID: 38194690
Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.
Cohen OC, Brodermann MH, Blakeney IJ, Mahmood S, Sachchithanantham S, Ravichandran S, Law S, Lachmann HJ, Whelan CJ, Popat R, Rabin N, Yong K, Kyriakou C, Shah R, Cheesman S, Worthington S, Hawkins P, Gillmore JD, Wechalekar AD. Cohen OC, et al. Among authors: ravichandran s. Amyloid. 2020 Sep;27(3):200-205. doi: 10.1080/13506129.2020.1765768. Epub 2020 May 15. Amyloid. 2020. PMID: 32408823 Clinical Trial.
The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis.
Cohen OC, Law S, Lachmann HJ, Sharpley F, Ravichandran S, Mahmood S, Sachchithanantham S, Whelan CJ, De Azcona Naharro AM, Fontana M, Hawkins PN, Gillmore JD, Wechalekar AD. Cohen OC, et al. Among authors: ravichandran s. Blood Cancer J. 2020 May 22;10(5):60. doi: 10.1038/s41408-020-0325-2. Blood Cancer J. 2020. PMID: 32444621 Free PMC article. No abstract available.
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.
Law S, Petrie A, Chacko L, Cohen OC, Ravichandran S, Gilbertson JA, Rowczenio D, Wechalekar A, Martinez-Naharro A, Lachmann HJ, Whelan CJ, Hutt DF, Hawkins PN, Fontana M, Gillmore JD. Law S, et al. Among authors: ravichandran s. ESC Heart Fail. 2020 Dec;7(6):3942-3949. doi: 10.1002/ehf2.12989. Epub 2020 Sep 13. ESC Heart Fail. 2020. PMID: 32924285 Free PMC article.
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis.
Palladini G, Paiva B, Wechalekar A, Massa M, Milani P, Lasa M, Ravichandran S, Krsnik I, Basset M, Burgos L, Nuvolone M, Lecumberri R, Foli A, Puig N, Sesta MA, Bozzola M, Cascino P, Nevone A, Ripepi J, Berti P, Casarini S, Annibali O, Orfao A, San-Miguel J, Merlini G. Palladini G, et al. Among authors: ravichandran s. Blood Cancer J. 2021 Feb 16;11(2):34. doi: 10.1038/s41408-021-00428-0. Blood Cancer J. 2021. PMID: 33594045 Free PMC article.
Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy.
Law S, Petrie A, Chacko L, Cohen OC, Ravichandran S, Gilbertson JA, Rowczenio D, Wechalekar AD, Martinez-Naharro A, Lachmann HJ, Whelan CJ, Hutt DF, Hawkins PN, Fontana M, Gillmore JD. Law S, et al. Among authors: ravichandran s. Heart. 2022 Mar;108(6):474-478. doi: 10.1136/heartjnl-2021-319063. Epub 2021 May 14. Heart. 2022. PMID: 33990410 Free PMC article.
Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal data.
Ravichandran S, Cohen OC, Law S, Sachchithanantham S, Mahmood S, Foard D, Fontana M, Martinez-Naharro A, Whelan C, Gillmore JD, Lachmann HJ, Hawkins PN, Wechalekar AD. Ravichandran S, et al. Br J Haematol. 2021 Aug;194(3):587-597. doi: 10.1111/bjh.17636. Epub 2021 Jun 29. Br J Haematol. 2021. PMID: 34189728
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis.
Cohen OC, Ismael A, Pawarova B, Manwani R, Ravichandran S, Law S, Foard D, Petrie A, Ward S, Douglas B, Martinez-Naharro A, Chacko L, Quarta CC, Mahmood S, Sachchithanantham S, Lachmann HJ, Hawkins PN, Gillmore JD, Fontana M, Falk RH, Whelan CJ, Wechalekar AD. Cohen OC, et al. Among authors: ravichandran s. Eur Heart J. 2022 Jan 31;43(4):333-341. doi: 10.1093/eurheartj/ehab507. Eur Heart J. 2022. PMID: 34472567
408 results